arrow
K

Kossara Drenovska

medical university-sofia
H指数:18
被引数:1,826

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-World Insights on Birch Triterpenes in the Treatment of Inherited Epidermolysis Bullosa: Translating Experience to Practice

桦树三萜类化合物在遗传性大疱性表皮松解症治疗中的现实世界见解:将经验转化为实践

2026-09-290
OAAI
International development of Investigator Global Assessment scores for pemphigus

investigator global assessment scores for pemphigus的国际化发展

2026-04-070
PRE
Standardized indirect immunofluorescence-based detection of dermal-binding autoantibodies in pemphigoid diseases: a prospective international multicentre study

基于标准化间接免疫荧光法检测大疱性皮肤病中真皮结合自身抗体的方法:一项前瞻性国际多中心研究

2025-10-010
OAAI
S2k guidelines on diagnosis and treatment of linear IgA dermatosis initiated by the European Academy of Dermatology and Venereology
2024-02-293
OAAI
The gut microbiome in bullous pemphigoid: implications of the gut-skin axis for disease susceptibility

大疱性类天疱疮中的肠道微生物组: 肠道皮肤轴对疾病易感性的影响

2023-11-105
OAAI
Serum reactivity in dermatitis herpetiformis: an international multicentre study
2023-10-042
PRE
S2k guidelines on the management of paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome initiated by the European Academy of Dermatology and Venereology (EADV) (vol 37, pg 1118, 2023)

由欧洲皮肤病学和性病学学会 (EADV) 发起的副肿瘤性天疱疮/副肿瘤性自身免疫性多器官综合征管理的S2k指南 (第37卷,1118页,2023)

2023-09-130
OA
S2k guidelines on the management of paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome initiated by the European Academy of Dermatology and Venereology (EADV)

S2k由欧洲皮肤病学和性病学学会 (EADV) 发起的副肿瘤性天疱疮/副肿瘤性自身免疫性多器官综合征管理指南

2023-03-2518
OA
Characterization of the skin microbiota in bullous pemphigoid patients and controls reveals novel microbial indicators of disease
2023-02-0111
OAAI
Serum autoantibody reactivity in bullous pemphigoid is associated with neuropsychiatric disorders and the use of antidiabetics and antipsychotics: a large, prospective cohort study
2022-07-154
OAAI
Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV)
2022-06-29110
OA
International multicentre observational study to assess the efficacy and safety of a 0.5 mg kg-1 per day starting dose of oral corticosteroids to treat bullous pemphigoid
2021-09-0212
OAAI
S2k guidelines (consensus statement) for diagnosis and therapy of dermatitis herpetiformis initiated by the European Academy of Dermatology and Venereology (EADV)
2021-05-1832
OAAI
Multicenter prospective study on multivariant diagnostics of autoimmune bullous dermatoses using the BIOCHIP technology
2020-11-0122
PREAI